| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PTC Therapeutics Inc (NASDAQ: PTCT)
PTCT Technical Analysis
4
| As on 9th Jun 2023 PTCT STOCK Price closed @ 43.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 41.32 & Strong Buy for SHORT-TERM with Stoploss of 39.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PTCTSTOCK Price
| Open | 42.42 | Change | Price | % |
| High | 43.42 | 1 Day | 0.44 | 1.03 |
| Low | 42.07 | 1 Week | 1.03 | 2.45 |
| Close | 43.00 | 1 Month | -9.64 | -18.31 |
| Volume | 484100 | 1 Year | 2.91 | 7.26 |
| 52 Week High 59.10 | 52 Week Low 25.60 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PTCT Daily Charts |
PTCT Intraday Charts |
Whats New @ Bazaartrend |
PTCT Free Analysis |
|
|
PTCT Important Levels Intraday
| RESISTANCE | 45.60 |
| RESISTANCE | 44.77 |
| RESISTANCE | 44.25 |
| RESISTANCE | 43.74 |
| SUPPORT | 42.26 |
| SUPPORT | 41.75 |
| SUPPORT | 41.23 |
| SUPPORT | 40.40 |
PTCT Forecast May 2024
| 4th UP Forecast | 58.15 |
| 3rd UP Forecast | 53.29 |
| 2nd UP Forecast | 50.29 |
| 1st UP Forecast | 47.28 |
| 1st DOWN Forecast | 38.72 |
| 2nd DOWN Forecast | 35.71 |
| 3rd DOWN Forecast | 32.71 |
| 4th DOWN Forecast | 27.85 |
PTCT Weekly Forecast
| 4th UP Forecast | 52.60 |
| 3rd UP Forecast | 49.52 |
| 2nd UP Forecast | 47.62 |
| 1st UP Forecast | 45.71 |
| 1st DOWN Forecast | 40.29 |
| 2nd DOWN Forecast | 38.38 |
| 3rd DOWN Forecast | 36.48 |
| 4th DOWN Forecast | 33.40 |
PTCT Forecast2024
| 4th UP Forecast | 110.12 |
| 3rd UP Forecast | 88.59 |
| 2nd UP Forecast | 75.29 |
| 1st UP Forecast | 61.98 |
| 1st DOWN Forecast | 24.02 |
| 2nd DOWN Forecast | 10.71 |
| 3rd DOWN Forecast | -2.59 |
| 4th DOWN Forecast | -24.12 |
PTC Therapeutics Inc ( NASDAQ USA Symbol : PTCT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PTCT Business Profile
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, including rare diseases and oncology. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of SMA in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; research collaboration with Massachusetts General Hospital for the treatment of rare genetic disorders resulting from pre-mRNA; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was founded in 1998 and is headquartered in South Plainfield, New Jersey. Address: 100 Corporate Court, South Plainfield, NJ, United States, 07080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service